Brief: ALX Oncology, Quantum Leap Healthcare CollaborativeTM Announce First Patient Dosed In I-SPY-P1 Trial
14/03/2023 13:29
March 14 (Reuters) - ALX Oncology Holdings Inc ALXO.O :
* ALX ONCOLOGY AND QUANTUM LEAP HEALTHCARE COLLABORATIVETM
ANNOUNCE FIRST PATIENT DOSED IN THE I-SPY-P1 TRIAL IN BREAST
CANCER
Source text for Eikon: ID:nPn2btwhKa
Further company coverage: ALXO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ALX Oncology Holdings
See all newsALX Oncology Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
ALX Oncology Holdings Inc expected to post a loss of 15 cents a share - Earnings Preview
ALX Oncology Q2 net loss narrows on lower R&D costs
Brief: ALX Oncology Q2 Basic EPS USD -0.13
Brief: Alx Oncology Holdings - Enters Loan And Security Agreement With HSBC Ventures On June 25, 2026 - SEC Filing